Adding Chemotherapy to Radiotherapy Not Associated with Improved OS for Patients with Intermediate-Risk Cervical Cancer By Ogkologos - April 7, 2025 948 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a cohort study conducted at Commission on Cancer accredited centres across the US Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Taking Control – Risks vs. Benefits July 14, 2020 TAT 2021 Honorary Award: A Recognition in Cancer Drug Development to... February 16, 2021 Survivors of Childhood Cancer are at Excess Risk of Late Mortality... April 21, 2023 Doctor Wipes Away The Debt Of 200 Cancer Patients January 6, 2021 Load more HOT NEWS Fear Pazopanib Is Not Inferior to Doxorubicin in First-Line Treatment of Elderly... Lung-Sparing Surgery Is Effective for Some with Early-Stage Lung Cancer EMA Recommends Extension of Indications for Venetoclax
